Cancer cells that harbor inactivating mutations in TP53 express only the corresponding p53 mutant protein; wild type protein expression is invariably lost via loss-of-heterozygosity (LOH) or gene silencing, as in DLD-1. This evidence concerns the gene TP53 and cancer.